Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 deals we've verified
111 providers, prices checked on their own sites. Partners that pay us a commission are listed first; that never changes our scores or prices. How we make money
Offer43%Off 2 mo
Featured partnerSesame Care8.0Our score
Sesame Care deal
Brand semaglutide (Wegovy)$199/mo was$349
First 2 months (starter doses), then $349/mo · New patients only
→Get this deal →
Verified Aug 2026; confirm at checkout. Prescription required. Paid placement: we earn a commission from this partner. Read our Sesame Care review
Prices are the ones each provider listed on the date shown. Many step up after the first month or apply only to a bundle; the plan line on each card is the provider's own wording. Never buy a GLP-1 from a source that doesn't require a prescription.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Lowest verified GLP-1 prices, October 2026
The cheapest discounted price we have verified for each option, across every provider we track (paying or not).
Best pathCompounded telehealthIntro offers from $49/mo; median ongoing $199/mo semaglutide, $249.995/mo tirzepatide
With no insurance, compounded telehealth intro offers are the lowest entry price in the market, and the ongoing median still beats manufacturer self-pay. (Compounded GLP-1s are not FDA-approved finished drugs; use a provider that requires a prescription.)
“GLP-1 coupon” is one of the most-searched phrases in the weight-loss medication market — and one of the most misunderstood. Traditional pharmacy coupons barely exist for these drugs. What exists instead is a stack of manufacturer programs, cash-pay channels, and telehealth introductory offers, each with its own eligibility fine print. The deals above are the telehealth layer; below are the manufacturer, cash-pay, and free-drug layers by who qualifies. For the full channel-by-channel walkthrough (Costco, Sam's Club, Amazon Pharmacy), see our GLP-1 cash-pay channel guide; for the cost-ascending decision framework, see the cheapest-GLP-1-without-insurance buyer's guide.
If you have commercial (employer or marketplace) insurance that covers the drug, the manufacturer savings card is the single biggest discount available — and it's free to enroll. Without coverage, LillyDirect and NovoCare sell the brand drug directly at cash self-pay prices. Every card shares the same exclusion: government-insured patients (Medicare, Medicaid, VA, DoD, TRICARE, state programs) are not eligible, even if they offer to pay cash outside their insurance. These are the manufacturers' own programs; we earn nothing from them.
Who pays $25, $299, or $499 for a GLP-1?
The number you actually pay depends entirely on your coverage status. Here are each manufacturer's published terms, lined up so you can find your own situation at a glance — the $25 column is the savings-card copay with commercial coverage, the middle column is the card price when your plan doesn't cover the drug, and the last column is the manufacturer's cash self-pay price. All figures are the brands' own published terms; blanks mean the manufacturer publishes no clean figure for that path.
Zepbound (tirzepatide)
With commercial coverage
Pay as little as $25 for a 1-, 2-, or 3-month fill with commercial coverage
Card price if plan doesn't cover
As low as $499/month for a 1-month fill via the savings card without commercial coverage
Cash self-pay
LillyDirect Self Pay vials start at $299/mo (2.5 mg) and $399/mo (5 mg); 7.5 mg is $499/mo and 10–15 mg $699/mo, or $449/mo for 7.5–15 mg when refilled within 45 days
Pay as little as $25 for any dose pen for up to a 3-month prescription with commercial coverage
Card price if plan doesn't cover
—
Cash self-pay
NovoCare self-pay: $199/mo for the first 2 monthly fills of 0.25 or 0.5 mg (new patients, through December 31, 2026), then $349/mo (0.25–1 mg) or $499/mo (2 mg)
Pay as little as $25 for a 1-, 2-, or 3-month fill with commercial coverage
As low as $499/month for a 1-month fill via the savings card without commercial coverage
LillyDirect Self Pay vials start at $299/mo (2.5 mg) and $399/mo (5 mg); 7.5 mg is $499/mo and 10–15 mg $699/mo, or $449/mo for 7.5–15 mg when refilled within 45 days
Pay as little as $25 for any dose pen for up to a 3-month prescription with commercial coverage
—
NovoCare self-pay: $199/mo for the first 2 monthly fills of 0.25 or 0.5 mg (new patients, through December 31, 2026), then $349/mo (0.25–1 mg) or $499/mo (2 mg)
Pay as little as $25 for up to a 3-month prescription with commercial coverage (if eligible)
As low as $499 for a 1-month fill if your commercial plan does not cover Mounjaro (savings capped at $647/month and $8,411 per calendar year)
—
Note the pattern: the $25 copay only exists with commercial coverage, and the middle-column card prices only apply if you have a commercial plan that happens not to cover the drug. If you're uninsured or government-insured, none of the savings-card columns apply to you — your real floor is either the cash self-pay column or the compounded telehealth route. The one exception is Medicare Part D: through the Medicare GLP-1 Bridge, eligible patients can get Wegovy for $50/month or Zepbound for no more than $50/month. Use the situation selector above to match your case, or jump straight to the cheapest semaglutide ranking for the lowest ongoing compounded price.
Savings card rejected at the pharmacy? Fix it
The savings card almost never auto-applies — the pharmacy has to run it as a secondary payer after your insurance. Hand the pharmacist your card's BIN, PCN, Group, and Member ID (they're printed on the card you activated online) and ask them to reprocess the claim with the manufacturer coupon as secondary. If they already billed insurance, they can reverse and rebill. If it still quotes full price, your plan may not cover the drug at all — in which case the card can only bring you to the middle-column 'plan doesn't cover it' price, not the $25 copay.
A 'BIN not found' or 'invalid BIN' rejection usually means the card wasn't activated, or the pharmacy typed the numbers wrong. Re-activate (or re-download) the card on the manufacturer's site — Zepbound, Wegovy, Ozempic, and Mounjaro each reissue cards annually and older BINs expire — then have the pharmacist re-key all four fields (BIN, PCN, Group, Member ID). Some independent pharmacy systems can't process manufacturer coupons at all; a large chain or the manufacturer's own preferred pharmacy usually can.
This is the classic January surprise. Most commercial plans reset the deductible on January 1, so until you meet the new-year deductible your insurance pays little and your share spikes — the savings card caps its help at a fixed dollar amount per fill (for example up to $100/month on the Novo Nordisk cards), so a big deductible bill can blow past the cap and leave you owing the difference. Nothing is broken; the card is still applying, it just can't cover a full-price deductible month. Check your plan's deductible status, and if the drug is on formulary this usually settles once the deductible is met.
If the drug isn't on your plan's formulary, the $25 copay is off the table — the savings card can only take you to the manufacturer's 'without commercial coverage' card price (the middle column above), not the insured copay. Two moves: (1) ask your prescriber to file a prior authorization or formulary exception, which is what actually unlocks coverage; and (2) in the meantime, compare that card price against the manufacturer's cash self-pay program and the compounded telehealth route, since one of those is often cheaper than the un-covered card price.
This is working as designed, not an error. Every manufacturer savings card — Zepbound, Wegovy, Ozempic, Mounjaro — legally excludes anyone with government insurance (Medicare, Medicaid, VA, DoD, TRICARE, or state programs), even if you offer to pay cash outside your plan. There is no workaround at the counter. If you have Medicare Part D, ask your prescriber about the Medicare GLP-1 Bridge: since July 1, 2026 it has covered Wegovy pen and pill for $50/month (through December 31, 2027) and Zepbound for no more than $50/month for patients who meet Medicare's clinical criteria. Otherwise your options are the manufacturers' cash self-pay programs (LillyDirect, NovoCare) or a compounded-GLP-1 telehealth intro offer. Manufacturer patient assistance programs do not cover Wegovy, Zepbound, Mounjaro or Foundayo.
Still stuck, or the card just doesn't apply to you?
If you're government-insured, uninsured, or your plan simply won't cover the drug, compounded telehealth skips the pharmacy counter and the insurance maze entirely — the price is applied at signup, with no card to reject. The lowest intro offer from a partner we work with right now: Live Vital, $99/mo compounded semaglutide (regularly $130/mo).
Compounded GLP-1s are not FDA-approved finished products, and intro pricing steps up afterward; see the deal card above for its terms.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The self-pay lines above are the second layer hiding inside the first: LillyDirect and NovoCare sell the brand-name drug directly to uninsured patients at $149–$499/month — already a 65–90% discount to retail list price, with no coupon, card, or insurance involved. If you are uninsured and want the FDA-approved brand product, start there before hunting coupon sites.
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 540+ providers' prices on their own sites and email you when tracked prices move.
Estimate your GLP-1 savings
Compare what you pay now against every access path — manufacturer self-pay, brand-with-insurance, and the telehealth deals above — to see your monthly, yearly, and 5-year savings.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
2026 monthly cost reference
Best-effort 2026 monthly cost snapshot for every common GLP-1 access path. Always confirm your actual price with your prescriber, pharmacy, or telehealth provider before committing.
Access path
Monthly
1 year
5 years
Semaglutide
Wegovy (commercial insurance + savings card)
$25
$300
$1,500
Wegovy NovoCare — first 2 months at 0.25 / 0.5 mg (new patients)
The deepest discount on paper isn't always the cheapest over a year — intro pricing steps up after month one. Our cost-per-pound calculator normalizes intro pricing against expected weight loss, and the cheapest semaglutide and cheapest tirzepatide rankings sort the whole market by ongoing price.
Do GoodRx and discount cards work on GLP-1s?
Before the layer-by-layer detail, here is every access path in one view — who each one is for, the real price, and where the discount cards actually land relative to the alternatives:
All five GLP-1 access paths, side by side
Program
Who qualifies
Typical price
Best for
Manufacturer savings card
Commercially insured, and your plan covers the drug. Government insurance (Medicare/Medicaid/VA/DoD/TRICARE) is excluded.
Copay as low as $25/mo
The commercially insured with a covered plan — the single deepest discount.
Manufacturer self-pay (LillyDirect / NovoCare)
Anyone, no insurance needed — buys the FDA-approved brand drug directly.
$149–$499/mo cash
Uninsured shoppers who specifically want the FDA-approved brand product.
GoodRx / discount card
Anyone, but barely moves patent-protected GLP-1 pricing.
10–20% off $1,000–$1,350 retail
Older weight-loss generics (phentermine, metformin, naltrexone) — not brand GLP-1s.
Medicare GLP-1 Bridge (Medicare Part D)
Medicare Part D enrollees, from July 1, 2026 (eligibility is set by Medicare). Savings cards still exclude every government plan, including Medicaid.
$50/mo for Wegovy (through December 31, 2027); no more than $50/mo for Zepbound
Medicare Part D enrollees with obesity — ask your prescriber about the Bridge. Medicaid enrollees should check their state plan's coverage.Medicare & Medicaid coverage guide →
Compounded telehealthBest for most
The uninsured and anyone whose plan won't cover a GLP-1 — the majority of shoppers.
The uninsured / non-covered majority — the lowest ongoing out-of-pocket price in the market.Compounded GLP-1s are not FDA-approved finished drugs; buy only from a provider that requires a prescription. Intro pricing steps up after the first month.
The uninsured / non-covered majority — the lowest ongoing out-of-pocket price in the market.
Compounded GLP-1s are not FDA-approved finished drugs; buy only from a provider that requires a prescription. Intro pricing steps up after the first month.
Compounded medians are computed live from our verified provider database. Only the compounded-telehealth row is an affiliate partner; every other path pays us nothing and is listed for honest comparison.
Mostly no — and this is the biggest surprise for coupon-first searchers. Traditional pharmacy discount cards (GoodRx, SingleCare, WellRx) negotiate off the cash retail price, and for patent-protected GLP-1s the cash retail price is $1,000–$1,350/month. A 10–20% card discount off that number still leaves you paying 2–3× the manufacturer's own self-pay program. GoodRx itself now routes GLP-1 searchers to manufacturer-program pricing rather than card discounts. Where the cards do help is the older generation: phentermine, metformin, naltrexone, and bupropion commonly drop under $20–$30/month with a card.
The Costco “GLP-1 discount”
Neither Costco nor Novo Nordisk currently publishes terms for the widely shared Costco GLP-1 deal, so ask your Costco pharmacy for a quote before you count on a specific price. The manufacturer's own published benchmark is NovoCare self-pay: $349/month for standard Wegovy pen doses and for Ozempic 0.25–1 mg, with $199/month for the first two fills of 0.25 or 0.5 mg for new patients. The full Costco / Sam's Club / Amazon Pharmacy channel comparison lives in the cash-pay channel guide.
Free GLP-1s: patient assistance programs
Both manufacturers run charitable patient assistance programs that supply medicine free to qualifying patients, but the GLP-1 lists are narrower than most coupon sites suggest. The Novo Nordisk Patient Assistance Program covers Ozempic, not Wegovy, for household income at or below 200% of the Federal Poverty Level (about $31,920 for a single person, or $66,000 for a family of four, in 2026). Lilly Cares does not list Zepbound, Mounjaro, or Foundayo; its only GLP-1 is Trulicity (dulaglutide), at or below 300% of the Federal Poverty Level ($47,880 for a single person, $99,000 for a family of four). Ozempic and Trulicity are type 2 diabetes medicines, so these programs help only if you are prescribed one for that use. Applications go through your prescriber. If your income is anywhere near a threshold, check PAP eligibility before paying for any layer above — the buyer's guide covers the application mechanics.
How we verify these deals
Source: every price comes from the provider's own website or checkout, never from coupon aggregator sites. Each card shows the month we last confirmed it, and cards older than 60 days ask you to confirm the price at checkout.
What counts as a deal: a listed price below the provider's own standard price for the same medication. Fees that exclude the medication (program or membership fees) are left out.
Codes: a code appears only when it is printed on the provider's own pricing. We never invent or guess codes.
Order and money: providers that pay us a commission are listed first and one appears in the featured slot; this never changes our editorial scores or the prices shown. See how we make money.
Safety: compounded GLP-1s are not FDA-approved products. Use a provider that requires a prescription and a medical review; our pharmacy legitimacy lookup checks who fills it.
GLP-1 coupon & discount FAQ
As of October 2026, the lowest verified telehealth price we track is $49/month for compounded semaglutide (Curex, standard $199) and $89/month for compounded tirzepatide (Southern Vitality and Weight Loss, standard $199). Intro prices often step up after the first month or apply to a bundle, so compare the standard price too. With commercial insurance that covers the drug, the brand-name manufacturer savings cards (Zepbound, Wegovy, Ozempic, Mounjaro) can bring the copay to as little as $25/month.
A few. Of the 111 providers we track with a verified deal, 12 use a typed code (Ondra Health: ONDRA15; Cora Health: CORA15; Effecty: SAVEMORE; Alloy: STARTGLP1; Pillar Health: PILLAR50; AJ Peptide: AJP_100; Citizen Meds: SALE20; MyFastRx: MY70; ReflexMD: FALLRESET15; Vyora Wellness: FALL50; TeleDocs360: NEWS10; Green Cap Health: GREEN50). Every other discount applies automatically at checkout, so a "promo code" site listing other codes is usually wrong. We show a code only when it appears on the provider's own pricing.
Yes. All four major GLP-1 brands have manufacturer savings cards: Zepbound, Wegovy, Ozempic, and Mounjaro cards cut copays to as little as $25/month for commercially insured patients whose plan covers the drug. Government-insured patients (Medicare, Medicaid, VA, DoD, TRICARE) are excluded from all four programs. Without commercial coverage, the manufacturers' own self-pay programs (LillyDirect, NovoCare) sell the brand drug for $149-$499/month cash.
In cost-ascending order: (1) patient assistance programs, if you have type 2 diabetes and a low income — the Novo Nordisk PAP supplies Ozempic free at or below 200% of the Federal Poverty Level, and Lilly Cares supplies Trulicity at or below 300%; neither program covers Wegovy, Zepbound, or Mounjaro; (2) telehealth compounded intro offers, with first-month pricing as low as $49-$99/month; (3) oral brand options via manufacturer self-pay — the Wegovy pill and Foundayo (orforglipron) both start at $149/month; (4) injectable brand self-pay via LillyDirect or NovoCare, from $199/month (NovoCare's new-patient price for the first two fills of 0.25 or 0.5 mg) up to $699/month (higher-dose Zepbound vials when not refilled within 45 days).
GoodRx lists GLP-1 pricing but traditional discount-card coupons barely move the $1,000-$1,350/month retail list price of patent-protected GLP-1s. Manufacturer self-pay programs ($149-$499/month) and telehealth intro offers beat discount cards by a wide margin for GLP-1s. Discount cards remain useful for older weight-loss generics like phentermine, metformin, and naltrexone, which commonly drop under $20-$30/month.
Neither Costco nor Novo Nordisk currently publishes terms for the widely shared Costco GLP-1 deal, so ask your Costco pharmacy for a quote before relying on a specific price. The manufacturer's own NovoCare self-pay price is $349/month for standard Wegovy pen doses and for Ozempic 0.25-1 mg, with $199/month for the first two fills of 0.25 or 0.5 mg for new patients.
Telehealth providers run legitimate introductory offers — usually automatic first-month pricing rather than codes you enter. Be skeptical of third-party coupon sites listing codes for GLP-1 medications: the offers tracked on this page are pulled from provider pricing we confirmed directly on each provider's own site. Never buy GLP-1 medication from a source that doesn't require a prescription.
The Zepbound single-dose pen card can be used for up to 13 fills per calendar year, saving up to $100 per 1-month fill capped at $1,300 per calendar year, and it expires 12/31/2026 (reissued annually). Wegovy and Ozempic commercial savings offers cap savings at $100/month. All four cards exclude government-insured patients.
Not the savings card. Every manufacturer savings card excludes government insurance — Medicare, Medicaid, VA, DoD, TRICARE, state programs — even if you offer to pay cash outside your plan. Medicare Part D has its own route instead: through the Medicare GLP-1 Bridge, which started July 1, 2026, eligible patients can get Wegovy pen or pill for $50/month (through December 31, 2027) or Zepbound for no more than $50/month, with a prescription that meets Medicare's clinical criteria. Otherwise your cash-pay routes are the manufacturers' self-pay programs (LillyDirect, NovoCare) or a compounded-GLP-1 telehealth intro offer. See our cheapest-semaglutide and cheapest-tirzepatide rankings for the lowest ongoing prices.
Yes. The Zepbound card expires 12/31/2026 and is reissued each year; manufacturers can modify or cancel any card at any time.
Ozempic NovoCare self-pay is $199/month for the first 2 fills of 0.25 or 0.5 mg (new patients, through 12/31/2026), then $349/month (0.25–1 mg) or $499/month (2 mg). Wegovy NovoCare self-pay pen is $199/month intro (0.25 & 0.5 mg, 2 fills through 12/31/2026), then $349/month standard; the Wegovy HD 7.2 mg pen is $399/month. See our cheapest-semaglutide ranking to compare against compounded options.
Yes — the Mounjaro savings card cuts commercially-insured copays to as little as $25 for up to a 3-month prescription (savings capped at $150 per 1-month fill and $1,950 per calendar year; the card expires 12/31/2026). If your commercial plan does not cover Mounjaro, the card brings a 1-month fill to as low as $499. Government-insured patients are excluded, and Lilly's own self-pay price for Mounjaro through LillyDirect starts at $499/month at every dose (pen only, no vial); for cheaper cash-pay tirzepatide, compare Zepbound LillyDirect vials.
7.Lilly Cares Foundation. Available medications and household income guidelines (2026 Federal Poverty Guidelines). lillycares.com. 2026. https://www.lillycares.com/how-to-apply
